To encourage German/Australian surgeons to adopt a proactive approach to glaucoma treatment and position canaloplasty as the preferred first-line Minimally Invasive Glaucoma Surgery (MIGS).
Key Findings:
Canaloplasty is implant-free and tissue-sparing, addressing the underlying cause of glaucoma.
Latest clinical data supports a proactive approach to glaucoma treatment.
Interpretation:
The webinar aims to enhance understanding and implementation of canaloplasty as a primary treatment for glaucoma by providing practical insights.
Limitations:
Focus is primarily on the German/Australian surgical context and may not address all aspects of glaucoma treatment.
The findings may not be generalizable to other regions.
Conclusion:
Embracing interventional glaucoma strategies like canaloplasty can significantly improve treatment outcomes by addressing the root causes of the disease.
